Alterations in sarcolemma proteins such as delta-sarcoglycan (SGCD), a member of the dystrophin-associated protein complex, also increase myofilament Ca2+ sensitivity, leading to diastolic dysfunction and cardiomyopathy (33, 34). The gene discussed is SGCD; the disease is cardiomyopathy.